VIVIMEDLAB (2)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE announces securities being included in ST-ASM framework with enhanced margin requirements of 50% to 100% effective February 11, 2026. | |||||||||||||||
NSE announces securities being included in ST-ASM framework with enhanced margin requirements of 50% to 100% effective February 11, 2026.
| |||||||||||||||
NSE imposes Short-Term Additional Surveillance Measure (ST-ASM) Stage I on 4 securities with increased margin requirements effective January … | |||||||||||||||
NSE imposes Short-Term Additional Surveillance Measure (ST-ASM) Stage I on 4 securities with increased margin requirements effective January 7, 2026, and excludes 2 securities from ASM framework.
| |||||||||||||||